Open AccessOvarian sertoli–leydig cell tumors: A multicenter long-term clinicopathological analysis of 27 patients
Author(s) -
Levent Akman,
İbrahim Egemen Ertaş,
Mehmet Gökçü,
Mustafa Coşan Terek,
Muzaffer Şancı,
Ulus Ali Şanlı,
Osman Zekioğlu,
Ahmet Özsaran
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.158037
Subject(s) - medicine , carboplatin , etoposide , regimen , germ cell tumors , chemotherapy , fertility preservation , ovary , surgery , cisplatin , gynecology , oncology , fertility , population , environmental health
Information on the clinical behavior of ovarian Sertoli-Leydig cell tumors (SLCTs) as well as its prognostic factors and optimal management is limited due to a substantially low incidence of the disease. Also, limited data is available regarding the role of chemotherapy in the management of SLCTs. The aim of the study is to evaluate clinicopathological features and outcome of patients with ovarian SLCTs.